Personal Investment Vitae

Home > Personal Investment Vitae

AYA Personal Investment Vitae as of May 2026
Chanel Holden @Chanel Holden
Platinum member since January 2017

Location: United States

Gender: Female

Asset investment style: Quantitative fundamental analysis

Market capitalization:

$8,138,452talents

Virtual portfolio value:

$5,090,598talents

Net overall return per annum:

18.98%

AYA current rank order:

#4

Asset investment philosophy:
Chanel Holden trades U.S. stocks with the top #1 to #500 positive alpha signals.

Top 10 profitable stock transactions since January 2020Strategy

Symbol Company Buy Sell Share Volume Return (%) Profit ($)
RMBL RumbleOn Inc. Class B Common Stock $0.36 $7.95 40,963 +2,108.33% $310,909
UBXG U-BX Technology Ltd. Class A Ordinary Shares $0.34 $3.98 36,511 +1,070.59% $132,900
UMAC Unusual Machines Inc. Common Stock $1.87 $18.73 6,638 +901.60% $111,917
SXTP 60 Degrees Pharmaceuticals Inc. Common Stock $0.15 $1.34 75,600 +793.33% $89,964
LSCC Lattice Semiconductor Corporation Common Stock $6.97 $48.04 2,096 +589.24% $86,083
VATE INNOVATE Corp. Common Stock $0.53 $4.14 21,396 +681.13% $77,240
SSNT SilverSun Technologies Inc. Common Stock $18.59 $130.48 593 +601.88% $66,351
NTZ Natuzzi S.p.A. $2.21 $11.92 6,612 +439.37% $64,203
CDNS Cadence Design Systems Inc. Common Stock $29.82 $150.85 490 +405.87% $59,305
LGVN Longeveron Inc. Class A Common Stock $3.45 $26.25 2,122 +660.87% $48,382
Sum $1,047,254

Top 10 current stock portfolio positions as of May 2026Strategy

Symbol Company Price Position Capitalization
SITM SiTime Corporation Common Stock $901.48 51 $45,975
AAON AAON Inc. Common Stock $141.70 312 $44,210
APT Alpha Pro Tech Ltd. Common Stock $6.64 6,336 $42,071
QURE uniQure N.V. Ordinary Shares $27.64 1,460 $40,354
MBX MBX Biosciences Inc. Common Stock $40.08 964 $38,637
NTRBW Nutriband Inc. Warrant $1.53 24,911 $38,113
NVCT Nuvectis Pharma Inc. Common Stock $11.06 3,404 $37,648
RDVT Red Violet Inc. Common Stock $46.90 778 $36,488
FIVN Five9 Inc. Common Stock $21.41 1,694 $36,268
ETON Eton Pharmaceuticals Inc. Common Stock $29.84 1,208 $36,046
Sum $395,810

Top 20 influencers

#1 - #5 #6 - #10 #11 - #15 #15 - #20
@alin
@Andy Yeh Alpha

Blog+More

Clayton Christensen defines the core dilemma of corporate innovation with sustainable and disruptive advances.

Daisy Harvey

2020-04-17 07:23:00 Friday ET

Clayton Christensen defines the core dilemma of corporate innovation with sustainable and disruptive advances.

Clayton Christensen defines and delves into the core dilemma of corporate innovation with sustainable and disruptive advances. Clayton Christensen (2000)

+See More

Macro eigenvalue volatility helps predict some recent episodes of high economic policy uncertainty.

James Campbell

2020-09-15 08:38:00 Tuesday ET

Macro eigenvalue volatility helps predict some recent episodes of high economic policy uncertainty.

Macro eigenvalue volatility helps predict some recent episodes of high economic policy uncertainty, recession risk, or rare events such as the recent rampan

+See More

Many young and mid-career Americans fall into the financial distress trap in rural communities.

John Fourier

2019-08-01 11:33:00 Thursday ET

Many young and mid-career Americans fall into the financial distress trap in rural communities.

Many young and mid-career Americans fall into the financial distress trap in rural communities. A recent analysis of 25,800 zip codes for 99% of the U.S. po

+See More

Tony Robbins summarizes several personal finance and investment lessons for the typical layperson.

Charlene Vos

2017-12-21 12:45:00 Thursday ET

Tony Robbins summarizes several personal finance and investment lessons for the typical layperson.

Tony Robbins summarizes several personal finance and investment lessons for the typical layperson: We cannot beat the stock market very often, so it w

+See More

Our proprietary alpha investment model outperforms most stock market indices from 2017 to 2023.

Daisy Harvey

2023-02-03 08:27:00 Friday ET

Our proprietary alpha investment model outperforms most stock market indices from 2017 to 2023.

Our proprietary alpha investment model outperforms most stock market indices from 2017 to 2023. Our proprietary alpha investment model outperforms the ma

+See More

Harvard macrofinance professor Robert Barro sees no good reasons for the recent sudden reversal of U.S. monetary policy normalization.

Laura Hermes

2019-09-09 20:38:00 Monday ET

Harvard macrofinance professor Robert Barro sees no good reasons for the recent sudden reversal of U.S. monetary policy normalization.

Harvard macrofinance professor Robert Barro sees no good reasons for the recent sudden reversal of U.S. monetary policy normalization. As Federal Reserve Ch

+See More